Hospital Universitario y Politécnico La Fe
Hospital Universitario y Politécnico La Fe
Valencia, Valencia, Spain3 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Molecular Study of the Maternal-fetal Interface in Preeclampsia. | Female Urogenital Diseases and Pregnancy Complications, Urogenital Diseases, hypertension, pregnancy-induced, preeclampsia, pregnancy disorder | Recruiting | Not stated | 2026-10-06 | NCT06232668 | |
| Evaluation of Materials for the Distribution of Pressure in the Treatment of Neuroischemic Ulcers | Diabetes Complications, Diabetic Foot, Foot Ulcer, Leg Ulcer, Skin Ulcer, Skin and Connective Tissue Diseases, cardiovascular disorder, diabetes mellitus, diabetic neuropathy, diabetic peripheral angiopathy, endocrine system disorder, skin disorder, vascular disorder | Recruiting | Not applicable | 2026-06-02 | NCT07620379 | |
| GammaGA: Prevalence of Acid Sphingomyelinase Deficiency Disease (ASMD) and Gaucher Disease in Patients With Monoclonal Gammopathies and/or Multiple Myeloma | Blood Protein Disorders, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Gaucher disease, Hemic and Lymphatic Diseases, Hypertrophy, Lipid Metabolism Disorders, Lipid Metabolism, Inborn Errors, Lysosomal Storage Diseases, Nervous System, Neoplasms by Histologic Type, Niemann-Pick disease, Nutritional and Metabolic Diseases, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Splenomegaly, brain disorder, cardiovascular disorder, central nervous system disorder, hematologic disorder, hemorrhagic disease, hereditary disease, histiocytosis, immune system disorder, immunoproliferative disorder, inborn errors of metabolism, lymphatic system disorder, lymphoproliferative syndrome, lysosomal lipid storage disorder, lysosomal storage disease, metabolic disease, monoclonal gammopathy, neoplasm, nervous system disorder, non-Langerhans cell histiocytosis, plasma cell neoplasm, sphingolipidosis, vascular disorder, vascular hemostatic disease | Recruiting | Not stated | 2026-02-11 | NCT05992532 |